SCHEMBL4639271

SCHEMBL4639271

COc1cccc(C(CNC(=O)NC2CCCC2)(c2ccccc2)c2cc(F)cc(C(F)(F)F)c2)n1

nearest known ligand 0.53

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ CETP P11597 19/20 0.53
▸ EPHX2 P34913 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4639671 0.82 CETP (0.66) CETP
SCHEMBL1182128 0.81 CETP (0.74) CETP
SCHEMBL4639267 0.81 CETP (0.52) CETPEPHX2
SCHEMBL4640328 0.80 CETP (0.59) CETP
SCHEMBL4639158 0.80 CETP (0.58) CETP
SCHEMBL4639196 0.80 CETP (0.67) CETP
SCHEMBL4639284 0.80 CETP (0.56) CETP
SCHEMBL4968917 0.78 CETP (0.48) CETPEPHX2
SCHEMBL4639174 0.78 CETP (0.69) CETP
SCHEMBL4639700 0.78 CETP (0.46) CETPEPHX2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1951673-A2 HETEROCYCLIC CETP INHIBITORS Bristol-Myers Squibb Company (US) 2008-08-06 — — EP disclosed
WO-2007062314-A2 HETEROCYCLIC CETP INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2007-05-31 — — WO disclosed
Send feedback